SABCS 2014: TNT Trial Commentary by Dr. Sunil Verma: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content